Patients’ Perception of Morocco’s Medicine Pricing Reform and Determinants of Their Access to Health Care and Medicine
Table 1
Characteristic and answer of the participating population.
(a)
Quantitative variable
Median, interquartile
Age
45 [31, 59]
Pharmaceutical expenditure (in euros)
30 [20, 60]
Blood and urinary analyzes expenditures (in euros)
15 [0, 50]
Doctor’s visit expenditures (in euros)
25 [0, 30]
Total care expenditures (2016) (in euros)
400 [200, 700]
(b)
Qualitative variable
Number (percentage)
Sex
M
127 (42.3%)
F
173 (57.7%)
Education level
Illiterate
32 (10.7%)
Primary
72 (24%)
Secondary
120 (40%)
University
76 (25.3%)
Health insurance coverage
Yes
180 (60%)
No
120 (40%)
Family status
Married
190 (63.3%)
Single
88 (29.3%)
Other
22 (7.3%)
Employment
Yes
198 (66%)
No
102 (34%)
Origin
Urban
242 (80.7%)
Rural
58 (19.3%)
Monthly income
Without income
71 (23.7%)
Less than 250 €
51 (17%)
Between 250 € and 500 €
97 (32.3%)
Between 500 € and 700 €
54 (18%)
Greater than 700 €
27 (9%)
Type of provider
General practitioner
119 (39.7%)
Specialist
161 (53.7%)
Never
20 (6.7)
Frequency of medical visit
Regularly when I am sick
156 (52%)
For chronic disease monitoring
112 (37.3%)
When I am sick and I have money
32 (10.7%)
Chronic diseases
Yes
126 (42%)
No
174 (58%)
100% coverage of healthcare expenses
Yes
12 (4.1%)
No
278 (92.7%)
Estimated monthly amount of health expenses
Yes
178 (59.3%)
No
122 (40.7%)
Delaying care
Yes
117 (39%)
No
183 (61%)
Share of health expenditures in family expenditures
Nothing
50 (16.7%)
Excessive
99 (33%)
According to needs and means
46 (15.3%)
Moderate
70 (23.3%)
Strictly necessary
34 (11.3%)
Informed on drop of drug prices
Yes
201 (67%)
No
99 (33%)
Costs of care before the prices drop
Expensive
166 (55.3%)
Moderate
75 (25%)
Insignificant
59 (19.7%)
Costs of care after the prices drop
Decrease in expenses
52 (17.3%)
Moderate
109 (36.3%)
No change
138 (46%)
Realizing that medicine prices are lower than in the past
Yes
86 (28.7%)
Moderately
79 (26.3%)
No
135 (45%)
Abnormally high price
Yes
215 (71.7%)
No
28 (9.3%)
Some medicines
57 (19%)
The price of the medicine is a barrier to access medicines and health care services
Yes
266 (88.7%)
No
34 (11.3%)
Better access to medicines after drop of prices
Yes
147 (49%)
No
152 (50.7%)
Significantly lower
Yes
130 (43.3%)
No
170 (56.7%)
Lower prices did not improve access to health care services for patients
Yes
126 (42%)
No
173 (57.7%)
Do you think that the impact of the “tiers payant” on medicine accessibility is more important than decrease medicine prices NB: “tiers payant” (i.e., direct payment of the health care providers by the payer instead of the reimbursement)
